US 11214565
Compound, compositions, and methods
granted A61PA61P25/16A61P25/28
Quick answer
US patent 11214565 (Compound, compositions, and methods) held by DENALI THERAPEUTICS INC. expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P25/16, A61P25/28, A61P29/00, A61P35/00